Homepage688235 • SHA
add
Beigene Ltd
Vorige slotkoers
¥ 238,40
Dag-range
¥ 238,93 - ¥ 246,38
Jaar-range
¥ 111,22 - ¥ 262,64
Beurswaarde
196,43Â mld. CNY
Gem. volume
2,81Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
SHA
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,12Â mld. | 48,64% |
Bedrijfskosten | 941,18Â mln. | 5,98% |
Netto inkomsten | 1,27Â mln. | 100,51% |
Netto winstmarge | 0,11 | 100,33% |
Winst per aandeel | 0,01 | 100,74% |
EBITDA | 42,73Â mln. | 118,01% |
Effectief belastingtarief | 93,92% | — |
Balans
Totale activa
Totale passiva
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 2,52Â mld. | -9,91% |
Totale activa | 5,84Â mld. | 3,07% |
Totale passiva | 2,34Â mld. | 1,50% |
Totaal aandelenvermogen | 3,50 mld. | — |
Uitstaande aandelen | 107,95 mln. | — |
Koers-boekwaardeverhouding | 7,35 | — |
Rendement op activa | 0,47% | — |
Rendement op kapitaal | 0,62% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 1,27Â mln. | 100,51% |
Operationele kasstroom | 44,08Â mln. | 114,29% |
Kasstroom uit beleggingen | -121,94Â mln. | 41,89% |
Kasstroom uit financiering | -33,78Â mln. | -120,81% |
Nettomutatie in liquide middelen | -108,16Â mln. | 71,43% |
Vrije kasstroom | -145,31Â mln. | 62,90% |
Over
BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has offices in North America, Europe, South America, Asia and Australia. BeiGene has a large presence in the Chinese market. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November, 2024 the company announced its intention to rebrand as BeOne Medicines. Wikipedia
Opgericht
28 okt 2010
Website
Werknemers
11.000
